$10.35
-0.35-3.27%
Last update: Nov 4, 4:00 PM
Fennec Pharmaceuticals Inc
FENCNASDAQ
The average analyst price target for Fennec Pharmaceuticals is $16.40, 58.5% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $14 to $18. The latest change came on Aug 12, 2026, when B. Riley Securities raised its price target on Fennec Pharmaceuticals from $16 to $18 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
